Man Group
XENT

Man Group’s Intersect ENT, Inc XENT Stock Holding History

Man Group’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,918
Closed -$224K – 1877
2020
Q1 		$224K Sell
18,918
-265,419
-93% -$5.88M ﹤0.01% 1445
2019
Q4 		$7.08M Sell
284,337
-374,697
-57% -$7.59M 0.02% 855
2019
Q3 		$11.2M Buy
659,034
+27,762
+4% +$505K 0.04% 532
2019
Q2 		$14.4M Buy
631,272
+231,472
+58% +$6.24M 0.05% 474
2019
Q1 		$12.9M Buy
399,800
+68,313
+21% +$2.11M 0.05% 465
2018
Q4 		$9.34M Buy
331,487
+321,198
+3,122% +$9.41M 0.04% 480
2018
Q3 		$296K Buy
10,289
+2,509
+32% +$75.4K ﹤0.01% 1957
2018
Q2 		$291K Sell
7,780
-172,024
-96% -$6.75M ﹤0.01% 1932
2018
Q1 		$7.07M Buy
+179,804
New +$6.57M 0.03% 651

Other funds holding XENT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Man Group's XENT Position: Q2 2020 in Review

Man Group sold out of Intersect ENT, Inc (XENT) in Q2 2020, closing a stake of 18,918 shares — an estimated $224K sold.

Man Group first reported a position in XENT in Q1 2018 and held it in 9 quarters. The position peaked at $14.4M in Q2 2019. 108 funds tracked by Wall St. Rank hold XENT as of Q2 2020.

  • Man Group reported no remaining Intersect ENT, Inc position as of Q2 2020 after selling out during the quarter.
  • Man Group sold 18,918 Intersect ENT, Inc shares in Q2 2020, an estimated $224K.
  • Man Group first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 9 quarters.
  • Man Group's Intersect ENT, Inc position peaked at $14.4M in Q2 2019.
  • 108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2020.

Based on Man Group's 13F filing for Q2 2020, filed 14 Aug 2020.